Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022

SELL
$255.51 - $362.11 $766 - $1,086
-3 Closed
0 $0
Q4 2021

Jan 19, 2022

SELL
$351.38 - $448.68 $1,756 - $2,243
-5 Reduced 62.5%
3 $1,000
Q3 2021

Oct 27, 2021

BUY
$372.64 - $458.3 $2,608 - $3,208
7 Added 700.0%
8 $3,000
Q1 2021

Sep 07, 2021

BUY
$249.67 - $299.48 $249 - $299
1 New
1 $1,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.